Navigation Links
New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered ,,

This technology essentially renders the body transparent and will allow physicians to determine whether gene therapies reach targeted cells and work as they should.

"The technology is expected to help patients with cancer and other illnesses, such as cardiovascular disease. The discovery is outlined in the August 2000, issue of the journal Nature Medicine. UCLA researchers plan to test the tracking system in prostate cancer patients within a year, and are working with researchers at other institutions to help them evaluate other gene therapy studies for cancer patients.

The tracking system consists of "reporter" genes that can be attached to any gene therapy and used to monitor the therapy's behavior. After the reporter genes and gene therapy are paired and infused into a patient, the patient receives an injection of a special radioactive molecule. The reporter genes produce a protein that traps the radioactive molecules, and the radioactivity causes the regions of the body in which the reporter gene is present to glow "hot" during a positron emission tomography (PET) scan. This will allow physicians to locate the reporter genes paired with the gene therapy and establish a picture of the treatment at work.
'"/>




Page: 1

Related medicine news :

1. UK Biobank Set Up To Understand the Links between Genes, Lifestyle Environment and Illness
2. Surprising Interaction Between Genes, Gender, and Hypertension
3. The Dangers Of Herb-Drugs Evaluated
4. The Effectiveness Of NSAIDs Evaluated
5. Weight-Loss Medication Evaluated By Nutrition Expert
6. Scientists To Re-Evaluate Bird Flu Threat
7. Students to Evaluate the Performance of Teachers
8. New Study Conducted To Evaluate The Success Of The Federal governments Funds For HIV/AIDS
9. University Evaluates New Device To Treat Brain Tumors
10. More Effective Chemotherapy for Breast Cancer Evaluated
11. Clinical Studies Evaluate Potential Treatments for Mouth Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... Therachat , a ... survey in an infographic on the current state of anxiety in support of National ... anxiety, was conducted in April 2017 and benchmarked general anxiety levels as well as ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... PITTSBURGH, PA (PRWEB) , ... May 22, 2017 , ... ... way to write with a pen. "My wife’s hand was damaged in a firework ... invent something that helps people with manual problems." , He then designed and created ...
(Date:5/22/2017)... ... 22, 2017 , ... Faithfully following pop culture, people today are forever in ... shaped through fitness programs. It carries on to skin nourished, pampered and nurtured to ... radiant smile. CDA has found that just like a perfectly cut and ...
(Date:5/21/2017)... ... May 19, 2017 , ... Chris Cornell, 52, was found dead on the night of Wednesday, ... most respected lead singers in the rock industry would take his own life, but the ... investigates how mental illness played a role in the death of Chris Cornell . ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: